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The antibacterial, antiviral and antiprotozoal
activities of fresh serum have been the subject
of numerous investigations, but the details of the
mechanisms by which these are affected are still
little understood. Properclin, a unique euglobulin,
found in the serum of man and many mammals
has recently been isolated by Pillemer and his
co-workers (1, 2, 3). This has stimulated wide
spread interest because of the essential role
attributed to properdin in one of the mechanisms
of non-specific immunity. This mechanism has
been demonstrated to be one of considerable
complexity. Its antibacterial activity, for ex-
ample, requires not only properdin but all four
components of complement and the presences of
magnesium ions (4, 5). The totality of these
constituents and their biological activities in this
immunological role is referred to as the properdin
system.
Studies of a preliminary nature in several
fields of investigation have implicated this
system as being one of importance. The properdin
system was demonstrated to be essential for the
hemolysis which occurs in the disease state of man
termed paroxysmal nocturnal hemoglobinuria (6).
Additional studies have dealt with the relation-
ship of this system to bacteria, viruses, and
protozoa (4, 5, 7, 8). It has been shown that the
properdin system is essential for the inactivation
of these organisms in fresh serum in vitro.
Furthermore, it has been demonstrated in
animals that the concentration of properdin in
serum may be altered to such a degree as to
significantly affect the severity of infection. This
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has been observed following total body irradi-
ation, severe hemorrhage, and injections of many
types of crude polysaccharide preparations from
diverse sources (9, 10, 11, 5).
It is the purpose of this paper to present our
preliminary data concerning properdin levels
found in man presumably normal and in certain
well defined disease states.
MATERIALS AND METHODS
The levels of properdin in sera were determined
by the method described by McNall (13). This
test differs from that developed by Pillemer (12)
in that a correction is made for the third com-
ponent of complement in the test serum, and the
unitage employed differs in that a wide spread of
numerical units is employed. The properdin
levels of apparently healthy male and female
Caucasians between the ages of 20 and 85 years,
were determined for the purpose of establishing
normal values. Members of the Caucasian and
Negro races between the ages of 20 and 40 have
been compared to detect any racial difference in
the levels of properdin.
In this preliminary study single properdin
determinations were made on the sera of patients
with a well defined disease state. These included
herpes zoster, discoid and disseminated lupus
erythematosus, pemphigus, psoriasis, atopic
dermatitis, diabetes mellitus, and patients with
various types of carcinomas. Because of the
preliminary nature of this report no attempt has
been made to follow individuals with serial de-
terminations. No consideration was given to the
stage of activity of the disease or to possible
fluctuations due to a large variety of medications
which the patients were receiving at the time the
blood samples were drawn.
Samples of blood were drawn and allowed to
clot in the refrigerator and then centrifuged at
4000 rpm for a period of ten minutes. The sera
were then removed and stored at —20°C in a
mechanical deep freeze. Properdiri determinations
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were made on the stored sera at approximately
weekly intervals.
RESULTS
The properdin concentrations of serum ob-
tained from apparently normal male and female
Caucasians between the ages of 20 and 85 years
have been determined. This data has been
plotted as to age and sex (Fig. 1).
A correlation between age and properdin level
was observed. Approximately ninety per cent of
the levels of properdin in the serum of the in-
dividuals in the youngest age group tested were
between 67 and 184 units per milliliter of serum,
whereas ninety per cent of the properdin levels of
serum obtained from individuals between the
ages of 71 and 85 years were between 17 and 84
units. A decrease was observed in the range of
properdin levels in the intermediate age groups.
No relationship between the level of properdin
and sex has been detected.
A racial difference in properdin levels was found
between normal Caucasians and normal Negroes
in the 20 to 40 age group in that a trend toward
lower properdin levels was observed in the Negro
race (Fig. 2).
1. Psoriasis. The concentrations of properdin
in 12 patients with psoriasis have been de-
termined. All of these patients were Caucasians.
For the purpose of comparison this data has been
superimposed on that obtained from normal
Caucasians of the same age groups (Fig. 3). No
significant differences were detected.
Normal Coucosians
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Fiu. 1. The level of properdin in normal
Caucasians. Properdin is expressed in units per
milliliter of serum. X represents a single determi-
nation from one individual. Males are arranged on
left of bar and females on the right.
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Fra. 3. The level of properdin in patients with
psoriasis and diabetes mellitus superimposed on
the range of normal Caucasians. The dotted bar
indicates the extended range of normal Negroes
in the age groups from 20 to 30 and from 31 to 40.
M represents a patient of Mexican ancestry and
N represents a Negro.
2. Diabetes Mellitus. The concentration of
properdin in 12 patients with diabetes mellitus
have been determined. One patient was a
Mexican, one a Negro and the remainder were
Caucasians. All appeared to be within the
normal or low normal range for their age groups
(Fig. 3).
3. Carcinomata. The concentration of pro-
perdin in 16 patients with various types of
carcinomata varying from superficial basal cells
to terminal carcinomatosis have been determined.
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FIG. 2. The level of properdin in normal negroes
superimposed on the range of normal Caucasians
of the same age group. X represents a single
determination from one individual. Males are
arranged on the left of bar and females on the
right.
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FIG. 4. The level of properdin in patients with
disseminated lupus erythematosus, discoid lupus
erythematosus, pemphigus, herpes zoster and
carcinoma. M represents an individual of Mexican
ancestry.
All of these patients were Caucasians (Fig. 4)
and no significant differences were detected.
4. Pemphigus. The concentration of properdin
in 5 patients with pemphigus of several types have
been determined. All were Caucasians (Fig. 4).
The levels of three of these patients are within
the normal ranges.
5. Lupus Erythematosus. The concentration of
properdin in 5 patients with discoid lupus
erythematosus and one with disseminated lupus
erythematosus have been determined (Fig. 4).
All of these patients were Caucasians. Two of the
patients with discoid lupus erythematosus had
concentrations of properdin within the normal
range while three of the patients with the same
disease had concentrations which were lower than
that considered normal for their age group. The
one patient with disseminated lupus erythema-
tosus had a concentration of properdin which was
considered lower than normal.
6. Herpes Zoster. The concentration of proper-
din in 6 patients with herpes zoster have been
determined (Fig. 4). The properdin concentration
in two of the patients who were Caucasians was
below that which was considered normal for
their age group. The concentrations in the re-
mainder fell within normal limits.
DI5CtS5ION
Since 1954 a great deal of attention has been
directed towards the study of properdin and the
properdin system in relationship to non-specific
immunity. Using the zymosan assay technic
(14) the concentration of properdin has been
found to vary considerably in normal individuals.
Generally normal levels have been found to vary
between 4 and 8 units per milliter of serum with
the lowest accepted limit being 2 units. Individ-
ual levels remain constant over many months; with
age and sex having no apparent influence on the
level of properdin. Racial differences in respect to
properdin have not been reported.
In this preliminary study utilizing the method
described by MeNall for the measurement of
properdin we have encountered certain dif-
ferences. Our data is fairly complete in respect to
normal adult Caucasians, but we have not as yet
surveyed the range of properdin in individuals
from birth to 20 years of age. We have found a
wide range in the amount of properdin in normal
individuals with the properdin concentration in
individuals in each of the age groups varying over
a two to three fold range. Our observations in-
dicate that the level of properdin decreases with
age in Caucasians between the ages of 20 to 85.
In those groups tested, the highest levels were ob-
served in the 20 to 40 age groups and the range
decreased in subsequent age groups. This de-
crease is roughly three-fold, thus it may be of
importance to take age into consideration when
evaluating the properdin concentration. No re-
lationship between sex and the level of pro-
perdin was found.
In respect to Negroes, we have at present only
sufficient data concerning individuals in the 20 to
30 age groups and 31 to 40 age groups. The
maximum levels of both the Caucasians and
Negroes in these age groups were essentially the
same but a large number of Negroes were found
to possess levels of properdin below that which
may be considered the normal range for Cau-
casians of these same age groups. No data con-
cerning the properdin concentration in Negroes is
available with which to compare these findings.
Additional studies are in progress.
The sampling of patients with the various
disease states is small, and the majority did not
show properdin levels significantly lower than
individuals in their age groups. In the case of
pemphigus, discoid and disseminated lupus
erythematosus and herpes zoster, several of the
patients had concentrations of properdin which
were considered lower than that of their normal
age groups. Serial determinations and the study
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of additional cases will be necessary to clarify
these findings.
SUMMARY
1. The concentrations of properdin of ap-
parently normal Caucasians have been de-
termined between the ages of 20 and 85. With
advancing age in those groups studied there was
a three-fold decrease in the range of levels of
properdin.
2. The concentration of properdin in normal
individuals varied over a two to three fold range
within all age groups studied.
3. The concentration of properdin in a large
number of Negroes was low when compared to
those of Caucasians of a similar age group.
4. The levels of properdin in patients with
carcinomatosis, pemphigus, lupus erythematosus,
herpes zoster, diabetes mellitus and atopic
dermatitis have been studied by single determi-
nations. Some individuals with herpes zoster,
lupus erythematosus and pemphigus had levels
which were lower than those considered normal
for their corresponding age groups.
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DISCUSSION
Da. FREDERIcK REIss (New York, N. Y.):I was present when Dr. Pillemer delivered his
paper on the properdin system and it was ex-
tremely challenging to listen to his findings.
From Newcomer's presentation there is ap-
parently no significant change present in the
various diseases which he investigated. I would
like to ask Dr. Newcomer, how he would explain
the therapeutic efficacy of properdin, which was
suggested as a protection and treatment in
ionizing radiation of mice.
DR. VICTOR D. NEWcOMER (in closing):
This is a new and expanding area of investigation.
There is a great deal of controversy concerning
the various technic for measuring properdin.
Improvemeat and refinements are to be cx-
pected. The role that properdin plays in a large
number of disease states in man still awaits more
detailed studies, and this presentation is a pre-
liminary survey for possible areas in dermatology
where this system may be of importance.
Tentatively at least it can be said that the
properdin system has been assigned an essential
role in non-specific immunity and is considered
important in the inactivation of certain types of
bacteria. In experimental animals which have re-
ceived total body irradiation it has been found
that a drop in the properdin levels occurs, thus
making the animals more susceptible to certain
infectious agents. When properdin is given in
sufficient amounts to such animals this suscepti-
bility to infection is prevented.
